Androgens and prostate cancer; pathogenesis and deprivation therapy.
about
Androgen Receptor Structure, Function and Biology: From Bench to BedsideSurgery and hormonal treatment for prostate cancer and sexual functionMechanisms of resistance in castration-resistant prostate cancer (CRPC)Diets rich in saturated and polyunsaturated fatty acids induce morphological alterations in the rat ventral prostateSilencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype.Targeting bone metabolism in patients with advanced prostate cancer: current options and controversies.Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis.Ligand-independent requirements of steroid receptors EcR and USP for cell survivalHonokiol inhibits androgen receptor activity in prostate cancer cellsLowered testosterone in male obesity: mechanisms, morbidity and management.Quality of Life and Sexual Health in the Aging of PCa Survivors.Consideration of GREB1 as a potential therapeutic target for hormone-responsive or endocrine-resistant cancers.The role of dietary fat throughout the prostate cancer trajectory.Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.MCL1 is a key regulator of steroidogenesis in mouse Leydig cells.Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.Can glycoprofiling be helpful in detecting prostate cancer?Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.Low free and bioavailable testosterone levels may predict pathologically-proven high-risk prostate cancer: a prospective, clinical trial.Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer.Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trialQuality of life decrements in men with prostate cancer undergoing androgen deprivation therapy.Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer.Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.Effects of androgen deprivation therapy on telomere length.Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer
P2860
Q26750866-68E845EA-598B-4EF1-A898-5778072D79B6Q26773774-D7AEE2C1-129E-41F7-84F5-2569CD858039Q26774221-D6D61672-5980-46BF-9E24-15A5BEFE4FD1Q33910958-D081251A-53C6-4863-ABF2-B05E9730C575Q34606029-AD515E9F-D4A4-45A2-AD69-872EA0A7E13BQ35087364-D066FB48-6CBC-4DD3-B57E-A47937494499Q36765569-E5EA7390-5905-4839-8764-BAB9A93D1C29Q37135281-B3B0B9B2-A12C-434B-8B5E-A48A044AB43CQ37354002-554AB8B1-4366-44E9-8888-240C2B1CFD15Q37625379-23C98D6E-79DE-4E4C-A96A-5E9820AA8F48Q37639196-FEDB76B3-37AA-40CD-8236-5169FF488E1BQ37686901-D0591009-40AE-4974-9735-D04C596DB7A9Q38226703-2FDBEB58-F3C1-4DF4-A390-E12B7208C81CQ38297476-10F8620C-8F53-4458-A13D-23709345D0AEQ38587219-6AB914A2-5960-47A1-AF09-B0BBFBB284AEQ38784785-D05DD933-4F61-4647-B618-3E4C32B57BFDQ38790667-74B9343F-FC07-470F-AABD-69D462F1BA7FQ38852467-50BB40BB-8147-4681-87FA-C37F77A0818BQ38897955-89F803B7-341F-4373-A7D1-A672D6D7F6F8Q40501272-A082C6A6-C0C0-4BC7-90B1-6D65EF86548FQ41097100-C233CD15-2A16-48C8-B8DE-92C30865E902Q42281198-4123395E-9339-469C-9ADF-63FA3EF65D04Q47628776-C79EB390-406F-430D-B98C-C19E3A2056BBQ47700604-16C88685-E301-4496-AE21-D2EA19F48E60Q47872641-45C3CFB5-4ECE-4989-BA8B-3038BFB573A7Q48098854-7046D7CF-2035-4638-A5D2-810B790238BFQ58294554-9E1318F9-B5F7-485B-BA5E-41428715993D
P2860
Androgens and prostate cancer; pathogenesis and deprivation therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Androgens and prostate cancer; pathogenesis and deprivation therapy.
@en
type
label
Androgens and prostate cancer; pathogenesis and deprivation therapy.
@en
prefLabel
Androgens and prostate cancer; pathogenesis and deprivation therapy.
@en
P1476
Androgens and prostate cancer; pathogenesis and deprivation therapy
@en
P2093
Jeffrey D Zajac
Mathis Grossmann
P304
P356
10.1016/J.BEEM.2013.05.001
P50
P577
2013-06-05T00:00:00Z